Mirador Therapeutics
Nori Ebersole is currently the Chief People Officer at Mirador Therapeutics, a precision medicine company focused on immunology and inflammation. Prior to this role, Nori held similar positions at companies such as Prometheus Biosciences, Inc., Urovant Sciences, Inc., Paul Hastings, LLC., Allergan, and the University of Southern California. Nori has a Bachelor of Science Degree in Business Administration and Management with an emphasis in Human Resource Management from USC Marshall School of Business.
This person is not in any offices
Mirador Therapeutics
Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly advance new precision medicines for patients living with chronic immune-mediated inflammatory and fibrotic diseases. Launched in 2024, Mirador has raised over $400 million from leading life sciences investors and is based in San Diego, CA.